SCHEMBL2619121

SCHEMBL2619121

O=CC(O)C(O)COP(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MPI P34949 1/20 1.00
PGD P52209 3/20 0.53
PGK1 P00558 1/20 0.47
PGK2 P07205 1/20 0.47
S1PR4 O95977 2/20 0.37
S1PR1 P21453 2/20 0.37
S1PR3 Q99500 2/20 0.37
S1PR5 Q9H228 2/20 0.37
S1PR2 O95136 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSPO P30536 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
LPAR5 Q9H1C0 1/20 0.36
SGPL1 O95470 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18341437 1.00 MPI (1.00) MPIPGDPGK1PGK2S1PR4
SCHEMBL2862562 1.00 MPI (1.00) MPIPGDPGK1PGK2S1PR4
SCHEMBL20455494 1.00 MPI (1.00) MPIPGDPGK1PGK2S1PR4
SCHEMBL891659 1.00 MPI (1.00) MPIPGDPGK1PGK2S1PR4
SCHEMBL50110 1.00 MPI (1.00) MPIPGDPGK1PGK2S1PR4
Phosphoric Acid SCHEMBL5613914 0.98 MPI (0.96) MPIPGDPGK1PGK2S1PR4
Phosphoric Acid SCHEMBL28420442 0.98 MPI (0.96) MPIPGDPGK1PGK2S1PR4
SCHEMBL20514347 0.92 MPI (0.85) MPIPGDPGK1PGK2S1PR4
SCHEMBL18341440 0.92 MPI (0.85) MPIPGDPGK1PGK2S1PR4
SCHEMBL18341412 0.91 MPI (0.82) MPIPGDPGK1PGK2S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119619354-A UPLC-MSMS-based method for detecting energy metabolite and application thereof 江苏三黍生物科技有限公司 2025-03-14 CN claimed
CN-118360173-A Method for synthesizing erythrose 4-phosphate precursor and erythritol 中国科学院微生物研究所 2024-07-19 CN claimed
CN-117187091-A Engineering bacterium for producing erythritol and application thereof 中国科学院微生物研究所 2023-12-08 CN claimed
CN-111363759-B Construction method of recombinant yarrowia lipolytica for synthesizing erythritol and bacterial strain thereof 上海交通大学 2022-12-30 CN claimed
CN-113388538-A Recombinant yeast, construction method and application thereof in preparation of tyrosol and derivative 山东恒鲁生物科技有限公司 2021-09-14 CN claimed
CN-111139194-B Recombinant yeast, construction method and application thereof in preparation of tyrosol and derivative 山东恒鲁生物科技有限公司 2021-06-25 CN claimed
WO-2020199952-A1 RECOMBINANT YEAST, CONSTRUCTION METHOD AND APPLICATION THEREOF IN PREPARING TYROSOL AND DERIVATIVES 烟台华康荣赞生物科技有限公司 2020-10-08 WO claimed
WO-2020199571-A1 RECOMBINANT YEAST, CONSTRUCTION METHOD, AND APPLICATION THEREOF IN PREPARING TYROSOL AND DERIVATIVES 烟台华康荣赞生物科技有限公司 2020-10-08 WO claimed
CN-111139194-A Recombinant yeast, construction method and application thereof in preparation of tyrosol and derivative 烟台华康荣赞生物科技有限公司 2020-05-12 CN claimed
EP-2021345-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'Oreal (FR) 2009-02-11 EP claimed
WO-2007137925-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'OREAL (FR) 2007-12-06 WO claimed
US-20260125713-A1 PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS BIOC3 (FR) 2026-05-07 US disclosed
US-20260035705-A1 ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY AGAIN BIO APS (DK) 2026-02-05 US disclosed
WO-2025055194-A1 GENETICALLY ENGINEERED BACTERIUM FOR DE NOVO SYNTHESIS OF VANILLIN USING GLUCOSE AS SUBSTRATE, AND USE THEREOF 北京化工大学 2025-03-20 WO disclosed
EP-4519442-A1 PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS BIOC3 (FR) 2025-03-12 EP disclosed
US-20100124583-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2010-05-20 US disclosed
EP-2021345-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'Oreal (FR) 2009-02-11 EP disclosed
CN-101300344-A Modified transketolase and use thereof DSM IP ASSETS BV (NL) 2008-11-05 CN disclosed
WO-2007137925-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'OREAL (FR) 2007-12-06 WO disclosed
CN-1371417-A Corynebacterium glutamicum genes encoding metabolic pathway proteins BASF AG (DE) 2002-09-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035705-A1 ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY ME1, FBP1, ME3 MPI 38/4885PGD 10/4885PGK1 44/4885
US-20260125713-A1 PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS MGAM, MRPL21, NOTUM MPI 469/4885PGD 106/4885PGK1 627/4885
US-20100124583-A1 PROCESSING BIOMASS FIP1L1, MANBA, BCAT2 MPI 122/4885PGD 59/4885PGK1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.